Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.

I’m joined by Alexander Zehnder, CEO of CureVac — a company that’s been pioneering mRNA technology for 25 years.

Alexander stepped into the CEO role in 2023 and has been leading CureVac through a critical transformation: securing a €1.45 billion partnership with GSK, executing a strategic pivot, and driving a major cultural shift within the organization. With a background in medicine and a career spanning Roche, Genentech, and Sanofi, he brings a unique perspective on what it takes to lead at scale while staying patient-focused.

We dive into the evolution of mRNA, the story behind CureVac’s next chapter, and the mindset needed to lead through change.

Enjoy and stay tuned.